These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18060329)

  • 21. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The long-term growth and development of children exposed to Depo-Provera during pregnancy or lactation.
    Pardthaisong T; Yenchit C; Gray R
    Contraception; 1992 Apr; 45(4):313-24. PubMed ID: 1387602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Body weight and body composition of depot medroxyprogesterone acetate users.
    Dal'Ava N; Bahamondes L; Bahamondes MV; Bottura BF; Monteiro I
    Contraception; 2014 Aug; 90(2):182-7. PubMed ID: 24780631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception.
    Heffron R; Mugo N; Were E; Kiarie J; Bukusi EA; Mujugira A; Frenkel LM; Donnell D; Ronald A; Celum C; Baeten JM;
    AIDS; 2014 Nov; 28(18):2771-6. PubMed ID: 25493602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Membranous dysmenorrhea: the forgotten entity.
    Rabinerson D; Kaplan B; Fisch B; Braslavski D; Neri A
    Obstet Gynecol; 1995 May; 85(5 Pt 2):891-2. PubMed ID: 7724151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of continuation rates for hormonal contraception among adolescents.
    Zibners A; Cromer BA; Hayes J
    J Pediatr Adolesc Gynecol; 1999 May; 12(2):90-4. PubMed ID: 10326194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spontaneous Membranous Dysmenorrhea in an Adolescent Girl: A Case Report and Literature Review.
    Topçu HO; Topçu S; Kokanalı D; Memur T; Doğanay M
    J Pediatr Adolesc Gynecol; 2015 Oct; 28(5):e139-41. PubMed ID: 26049935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depot medroxyprogesterone acetate contraception. Metabolic parameters and mood changes.
    Westhoff C
    J Reprod Med; 1996 May; 41(5 Suppl):401-6. PubMed ID: 8725702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone mineral density at various anatomic bone sites in women receiving combined oral contraceptives and depot-medroxyprogesterone acetate for contraception.
    Wanichsetakul P; Kamudhamas A; Watanaruangkovit P; Siripakarn Y; Visutakul P
    Contraception; 2002 Jun; 65(6):407-10. PubMed ID: 12127638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case-control study of breast cancer and hormonal contraception in Costa Rica.
    Lee NC; Rosero-Bixby L; Oberle MW; Grimaldo C; Whatley AS; Rovira EZ
    J Natl Cancer Inst; 1987 Dec; 79(6):1247-54. PubMed ID: 2961909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of long-acting contraceptives in adolescents.
    Harel Z; Cromer B
    Pediatr Clin North Am; 1999 Aug; 46(4):719-32. PubMed ID: 10494253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hormonal contraception].
    Van Cauwenberge JR
    Rev Med Liege; 1992 May; 47(5):221-36. PubMed ID: 1604074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera) as a contraceptive agent.
    Jeppsson S; Gershagen S; Johansson ED; Rannevik G
    Acta Endocrinol (Copenh); 1982 Mar; 99(3):339-43. PubMed ID: 6461995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immediate start of hormonal contraceptives for contraception.
    Lopez LM; Newmann SJ; Grimes DA; Nanda K; Schulz KF
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006260. PubMed ID: 18425943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians.
    Kaunitz AM
    Int J Fertil Womens Med; 1998; 43(2):73-83. PubMed ID: 9609206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Membranous dysmenorrhea or passage of a decidual cast - forgotten phenomenon but not rare? Case report and summary of the literature].
    Brehmer L; Engberg H
    Lakartidningen; 2022 Nov; 119():. PubMed ID: 36321300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of hormonal contraception on mood and sexual interest among adolescents.
    Ott MA; Shew ML; Ofner S; Tu W; Fortenberry JD
    Arch Sex Behav; 2008 Aug; 37(4):605-13. PubMed ID: 18288601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of depot medroxyprogesterone acetate on fracture risk: a case-control study from the UK.
    Kyvernitakis I; Kostev K; Nassour T; Thomasius F; Hadji P
    Osteoporos Int; 2017 Jan; 28(1):291-297. PubMed ID: 27461017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preventing repeat teen pregnancy: postpartum depot medroxyprogesterone acetate, oral contraceptive pills, or the patch?
    Thurman AR; Hammond N; Brown HE; Roddy ME
    J Pediatr Adolesc Gynecol; 2007 Apr; 20(2):61-5. PubMed ID: 17418388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reasons for contraceptive discontinuation in women 20-39 years old in New Zealand.
    Colli E; Tong D; Penhallegon R; Parazzini F
    Contraception; 1999 Apr; 59(4):227-31. PubMed ID: 10457866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.